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Abstract
Background: Anatomic atrial enlargement is associated with significant morbidity and mortality.
However, atrial enlargement may not correlate with clinical measures such as electrocardiographic
(ECG) criteria. Past studies correlating ECG criteria with anatomic measures mainly used inferior
M-mode or two-dimensional echocardiographic data. We sought to determine the accuracy of the
ECG to predict anatomic atrial enlargement as determined by volumetric cardiovascular magnetic
resonance (CMR).
Methods: ECG criteria for left (LAE) and right atrial enlargement (RAE) were compared to CMR
atrial volume index measurements for 275 consecutive subjects referred for CMR (67% males, 51
± 14 years). ECG criteria for LAE and RAE were assessed by an expert observer blinded to CMR
data. Atrial volume index was computed using the biplane area-length method.
Results: The prevalence of CMR LAE and RAE was 28% and 11%, respectively, and by any ECG
criteria was 82% and 5%, respectively. Though nonspecific, the presence of at least one ECG
criteria for LAE was 90% sensitive for CMR LAE. The individual criteria P mitrale, P wave axis <
30°, and negative P terminal force in V1 (NPTF-V1) > 0.04s·mm were 88–99% specific although not
sensitive for CMR LAE. ECG was insensitive but 96–100% specific for CMR RAE.
Conclusion: The presence of at least one ECG criteria for LAE is sensitive but not specific for
anatomic LAE. Individual criteria for LAE, including P mitrale, P wave axis < 30°, or NPTF-V1 >
0.04s·mm are highly specific, though not sensitive. ECG is highly specific but insensitive for RAE.
Individual ECG P wave changes do not reliably both detect and predict anatomic atrial enlargement.
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Introduction
Atrial enlargement is a marker of increased cardiovascular
events. Anatomic left atrial (LA) enlargement (LAE) is a
marker of left ventricular (LV) diastolic dysfunction [1]
and is associated with an abnormal stress test in subjects
with known or suspected coronary artery disease [2]. In
addition, it is a predictor for the development of atrial
fibrillation [3-6], congestive heart failure [6], stroke [7],
increased cardiac mortality [7,8], incidence and survival
after myocardial infarction [9-11], and combined cardio-
vascular events [10,12]. Right atrial (RA) enlargement
(RAE) is associated with increased risk for congestive heart
failure [13] and increased mortality in patients with pri-
mary pulmonary hypertension [14].
The electrocardiogram (ECG) is used ubiquitously in clin-
ical practice to evaluate patients with cardiac disease. ECG
criteria for atrial enlargement have shown poor sensitivity
and moderate specificity for detecting enlargement as
defined by two-dimensional echocardiography paraster-
nal long axis (PLAX) and four-chamber (4 Ch) measure-
ments [15-23]. However, echocardiographic measures are
subject to error due to variability in acquisition of appro-
priately aligned images, limitations in acoustic windows,
and other causes of technical variation. In addition,
because the LA is not a sphere with a constant radius [24],
uni- or two- dimensional (2-D) echocardiographic meas-
urements may not reflect true chamber size. Cardiovascu-
lar magnetic resonance (CMR) imaging can provide
images in standardized planes, thereby providing more
precise volumetric assessment of cardiac chamber size. We
sought to determine the accuracy of the ECG for detection
of atrial enlargement (AE) using the gold standard of vol-
umetric CMR.
Methods
Study population
The study population consisted of 275 consecutive sub-
jects referred for CMR either for clinical (n= 255) or
research (n = 20) purposes, between February 2001 and
July 2004. Clinical CMR indications included evaluation
for the following: left ventricular function (n = 111), pul-
monary veins (n = 74), coronary arteries (n = 47), per-
fusion and/or viability (n = 43), cardiomyopathy (n = 38),
intracardiac shunt (n = 4), valvular function (n = 3), peri-
cardium (n = 2), myocarditis (n = 1), and cardiac mass (n
= 1). Many subjects were referred for more than one indi-
cation. Subjects were excluded if no sinus rhythm ECG
was available (see below). Age, gender, height, weight, as
well as history of atrial fibrillation (AF) and hypertension
were recorded. Research subjects gave informed consent
according to a protocol approved by the hospital institu-
tional review board.
Electrocardiography
A standard 12-lead ECG was performed on the same day
of the CMR in all subjects in sinus rhythm (n = 201). An
ECG in sinus rhythm, no more than 35 days from the
CMR scan and prior to any pulmonary vein ablation pro-
cedures, was obtained for subjects with AF (n = 74). ECG
LAE was defined by any one of the following: 1) P wave in
any lead > 0.11s, 2) Notched P wave with interpeak dura-
tion > 0.04s (P mitrale), 3) P wave axis < 30°, 4) Area of
negative P terminal force in lead V1 (NPTF-V1) >
0.04s·mm, or 5) Positive P terminal force in aVL (PPTF-
aVL) > 0.5 mm [16,18,23,25]. ECG RAE included 1) P
wave in inferior leads II, III, aVF > 2.5 mm or 2) Positive
P wave in V1 > 1.5 mm [26,27]. All ECG determinations
were made by one experienced observer (MEJ) blinded to
other results.
CMR technique
CMR was performed on a 1.5T whole-body scanner
(Gyroscan NT, Philips Medical Systems, NL). Among sub-
jects with AF, the CMR scan was performed prior to any
pulmonary vein isolation procedure. Participants were
imaged in the supine position with a phased-array five-
element cardiac synergy coil for radiofrequency signal
reception. Localizing scans were followed by free-breath-
ing axial spin-echo (repetition time 800 ms, echo time 20
ms, field of view 300 mm, matrix size 192 × 512, slice
thickness 6 mm, 0.5 mm gap) and end-expiratory, breath-
hold, ECG-gated SSFP acquisitions (temporal resolution
33 ms, repetition time 3.1 ms, echo time 1.6 ms, flip angle
60 degrees, field of view 400 mm, matrix size 208 × 256,
slice thickness 10 mm, gap = 0).
Image analysis
CMR analyses were performed using dedicated software
(EasyVision 5.1, Philips Medical Systems, Best, NL). LA
length was measured from the posterior wall to the plane
of the mitral annulus, parallel to the long-axis of the heart,
in the two-chamber (2 Ch) and four-chamber (4 Ch) ori-
entations on cine SSFP acquisitions at maximum atrial
diastole (Figure 1A, B). Maximum atrial diastole was
defined as the image immediately preceding the opening
of the mitral and tricuspid valves. Similarly, RA length was
measured from the posterior wall of the RA to the plane of
the tricuspid annulus in the 4 Ch orientation (Figure 1B).
LA area in apical 2 Ch and 4 Ch orientation were planim-
etered by tracing the endocardial border in maximum
atrial diastole, excluding the confluence of the pulmonary
veins and LA appendage (Figure 1C, D). Similarly, the 4
Ch RA area was planimetered, excluding the confluence of
the vena cavae and the atrial appendage (Figure 1D). The
borders of the atria were delimited at the planes of the AV
annulus and the junctions of venous inflow. Atrial vol-
umes were calculated according to the biplane area-length
method, then indexed for body surface area (BSA) [28-Journal of Cardiovascular Magnetic Resonance 2008, 10:7 http://www.jcmr-online.com/content/10/1/7
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30]. Enlarged CMR volume index was defined to be ≥ 55
ml/m2, two standard deviations (SD) above the mean of
normal, healthy subjects in published population studies
[31-36]. CMR analyses were performed by two experi-
enced observers (CWT, TDO) blinded to other results.
Statistical analysis
Continuous data are presented as mean ± SD. Categorical
data are presented as counts and percentages. The differ-
ence in continuous measures between subject subgroups
was assessed using Student's t test. The difference in cate-
gorical measures between subject subgroups and the prev-
alence of AE among the subject subgroups were assessed
using Fisher's exact test. Sensitivity, specificity, positive
predictive value (PPV) and negative predictive value
(NPV) were used to assess the test performance for ECG
LAE and RAE. The accuracy of ECG LAE and RAE were
computed individually and in combination. The inde-
pendent relationships of hypertension and CMR LAE to
ECG LAE were further evaluated with logistic regression. A
p-value of ≤ 0.05 was considered statistically significant.
All statistical analyses were performed using SAS for Win-
dows (v.9.1, SAS Institute, Cary, NC).
Results
Study population
The 275 study subjects consisted of 184 (67%) males, 91
females (age 51 ± 14 years; range 18 to 83 years) who were
consecutively referred for clinical or research CMR study,
including 27% subjects with a history of AF and 34% with
a history of hypertension. For the entire group, CMR LA
and RA volumes were 97 ± 38 ml and 79 ± 32 ml, respec-
CMR images with representative measurements at atrial end-diastole Figure 1
CMR images with representative measurements at atrial end-diastole. (A) Two-chamber (2 Ch) view with left atrial (LA) length 
measurement. (B) Apical four-chamber (4 Ch) view with LA and right atrial (RA) 4 Ch length measurement. (C) 2 Ch view with 
LA endocardial border tracings. (D) 4 Ch view with LA and RA endocardial border tracings. P: Posterior. L: Left.
A B
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tively, and LA and RA volume indices were 49 ± 17 ml/m2
and 40 ± 15 ml/m2, respectively. The prevalence of CMR
AE and ECG AE is presented in Table 1. Normotensive
subjects and those with a history of hypertension had a
similar prevalence of CMR LAE (30%, p = 1.0). Compared
to subjects in sinus rhythm, subjects with a history of AF
had a significantly higher prevalence of CMR LAE and but
not CMR RAE (Figure 2).
Accuracy of ECG for anatomic atrial enlargement
The accuracy of ECG LAE is presented in Table 2. The pres-
ence of at least one ECG LAE criteria had a sensitivity of
90% with a NPV of 84% and specificity of 21% for detec-
tion of CMR LAE. When ECG criteria were analyzed inde-
pendently, P wave > 0.11s offered the highest sensitivity
for CMR LAE, with a NPV of 85%. Three individual ECG
criteria were very specific for detecting CMR LAE. The pres-
ence of P mitrale, P wave axis < 30°, and NPTF-V1 >
0.04s·mm were 99%, 90%, and 88% specific, respec-
tively, for detecting CMR LAE, although these criteria were
not sensitive. The presence of P mitrale had a high PPV of
86% for CMR LAE.
The ECG was insensitive but highly specific for CMR RAE
(Table 2). The presence of P wave in leads II, III, or aVF >
2.5 mm or positive P wave in V1 > 1.5 mm had specifici-
ties of 100% and 96%, respectively, for diagnosing CMR
RAE. Both criteria had a NPV of 90%, indicating low rates
of false-negative results.
Association of hypertension with ECG LAE
Because hypertension may affect P wave characteristics on
ECG independently of atrial size [37], we performed logis-
tic regression to assess the independent relationships of
hypertension and CMR LAE to ECG LAE. With simultane-
ous adjustment, only CMR LAE, and not the presence of
hypertension, was significantly associated with ECG LAE
(OR 2.9, 95% CI 1.2 to 7.3, p = 0.023).
Discussion
The commonly used ECG criteria for atrial enlargement
have been compared to anatomic atrial size by M-mode or
2-D echocardiography [15-23,38], which have inherent
disadvantages including limited acoustic windows and
spatial resolution, geometric assumptions made for esti-
mation of atrial size, and moderate interobserver variabil-
ity of measurements. The goal of this study was to
characterize the accuracy of commonly used ECG atrial
enlargement criteria against a gold standard of volumetric
CMR measurements.
The presence of any ECG LAE criteria was 90% sensitive
with a NPV of 84%, but had poor specificity of only 21%
for CMR LAE. Using a combination of ECG LAE criteria is
thus highly sensitive for detection of anatomic LAE, with
a low false negative rate. This study indicates that com-
monly used ECG LAE criteria are more sensitive for ana-
tomic LAE than the 6–69% sensitivity previously reported
using echocardiographic standards [16,18,22,23,38]. The
criteria of P mitrale, P wave axis < 30°, and terminal P
wave in V1 > 0.04s·mm were each highly specific
although not sensitive for CMR LAE. In our CMR study,
we found higher specificities of P mitrale and terminal P
wave in V1 > 0.04s·mm for anatomic LAE than those
obtained by similar atrial bi-plane volume analysis using
2-D echocardiography [38]. In addition, the high specifi-
city of the criteria of P wave axis < 30° to detect LAE has
not been previously described to our knowledge. Com-
pared with prior M-mode echocardiographic studies
[16,18,23,25], we found higher sensitivity but lower spe-
cificity for P > 0.11s, and similar excellent specificity for P
mitrale and NPTF-V1 > 0.04s·mm to detect CMR LAE.
The overall increased sensitivity of ECG LAE compared to
ECG RAE may be explained by a larger number of criteria
used, as well as high prevalence of the very sensitive crite-
ria P > 0.11s.
Our results indicate that ECG criteria are insensitive but
highly specific to detect CMR RAE, and are in agreement
with analyses using echocardiographic volumetric RAE
[39]. We found similar sensitivity but greatly improved
specificity and both positive and negative predictive val-
ues of ECG for CMR RAE compared to 2-D echocardio-
graphic standards [40]. No individual ECG criteria had
both high sensitivity and specificity for predicting ana-
tomic RAE. Though many of the commonly used individ-
ual ECG LAE and RAE criteria have high specificity for
anatomic AE, their prevalence is rare even in our referral
population.
Prevalence of CMR atrial enlargement (AE) among subjects in  sinus rhythm (SR) and with atrial fibrillation (AF) Figure 2
Prevalence of CMR atrial enlargement (AE) among subjects in 
sinus rhythm (SR) and with atrial fibrillation (AF). Subjects 
with AF have a significantly higher prevalence of left (LAE) 
but not right atrial enlargement (RAE), compared with sub-
jects in SR.
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Our CMR measurements are in agreement with Anderson
et al [41], who reported higher CMR normative upper ref-
erence range atrial dimensions compared to echocardio-
graphic standards. Though our mean volume indices
exceed normative values by the American Society of
Echocardiography [42], CMR volumetric measures have
been shown to exceed that of echocardiography by 14–
37% [41,43]. CMR measurements in this study are con-
sistent with those obtained in past CMR studies [29,32-
36], which published upper limits of normative LA vol-
umes ranging 50–69 ml/m2. Within CMR studies, there is
a range of volumes reported in healthy subjects, with
smaller volumes found in studies with younger, as
opposed to middle-aged, subjects [36,44,45].
Abnormalties in atrial conduction resulting from hyper-
tension, elevated pulmonary capillary wedge pressure, or
intrinsic conduction defects are associated with abnor-
malities in the P wave [37,46,47] and may be independ-
ent of atrial size. Thus, it is not surprising that in our
study, ECG LAE criteria were sensitive but not specific.
Since multiple etiologies may account for similar conduc-
tion disturbances in the P wave, the manifestation of such
ECG criteria may be more accurately described as indicat-
ing atrial "abnormality" rather than "enlargement".
In logistic regression analysis, we demonstrated that CMR
LAE was associated with ECG LAE independently of
hypertension. However, a limitation of our study was that
Table 1: Prevalence of Atrial Enlargement by CMR and ECG
LAE RAE
CMR Criteria
Volume index ≥ 55 ml/m2 28% Volume index ≥ 55 ml/m2 11%
ECG Criteria
Any ECG criteria for LAE 82% Any ECG criteria for RAE 5%
P > 0.11s 70% Inferior P waves > 2.5 mm 1%
P mitrale 3% Positive P wave in V1 > 1.5 mm 4%
P axis < 30° 9%
NPTF-V1 > 0.04s·mm 16%
PPTF-aVL > 0.5 mm 41%
CMR: Cardiovascular magnetic resonance. ECG: Electrocardiography. LAE: Left atrial enlargement. RAE: Right atrial enlargement. P mitrale: 
Notched P wave with interpeak duration > 0.04s. NPTF-V1 > 0.04s·mm: Area of negative P terminal force in lead V1 > 0.04s·mm. PPTF-aVL: 
Positive P terminal force in lead aVL. Inferior P waves: P wave in any of the leads II, III, or aVF.
Table 2: Accuracy of ECG criteria for Left and Right Atrial Enlargement as Detected by CMR
ECG Criteria Sensitivity (%) Specificity (%) PPV (%) NPV (%)
LAE
Any ECG Criteria for LAE 90 21 31 84
P > 0.11s 84 35 34 85
P mitrale 89 9 8 6 7 4
P axis < 30° 8 90 23 71
NPTF-V1 > 0.04s·mm 37 88 47 76
PPTF-aVL > 0.5 mm 44 60 30 73
RAE
Any ECG Criteria for RAE 17 96 33 91
Inferior P waves > 2.5 mm 71 0 0 6 7 9 0
Positive P wave in V1 > 1.5 mm 10 96 25 90
CMR: Cardiovascular magnetic resonance. ECG: Electrocardiography. PPV: Positive predictive value. NPV: Negative predictive value. LAE: Left atrial 
enlargement. RAE: Right atrial enlargement. P mitrale: Notched P wave with interpeak duration > 0.04s. NPTF-V1 > 0.04s·mm: Area of negative P 
terminal force in lead V1 > 0.04s·mm. PPTF-aVL: Positive P terminal force in lead aVL. Inferior P waves: P wave in any of the leads II, III, or aVF.Journal of Cardiovascular Magnetic Resonance 2008, 10:7 http://www.jcmr-online.com/content/10/1/7
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we were not able to adjust for other factors which may
affect P wave morphology, such as the use of sodium
channel blocking medications, as this information was
unavailable. In addition, since this study was noninvasive,
we were not able to measure atrial pressures, which may
also affect the P wave [46].
Conclusion
Our results further validate the strengths and weaknesses
of commonly used ECG LAE and RAE criteria against the
gold standard of anatomic measurements. Compared
with volumetric CMR measures, none of the commonly
used ECG LAE or RAE criteria provided high accuracy for
detecting anatomic LAE or RAE. High sensitivity was
achieved only with lower specificity and vice versa. The
presence of any ECG LAE criteria and the individual crite-
rion of P > 0.11s were highly sensitive for CMR LAE, while
the criteria P mitrale, P wave axis < 30°, and NPTF-V1 >
0.04s·mm were very specific, though poorly sensitive, for
detecting CMR LAE. ECG RAE criteria were highly specific,
though insensitive, for detecting anatomic RAE. The lim-
ited specificity of the most sensitive ECG criteria for ana-
tomic atrial enlargement is consistent with the fact that P
wave perturbations reflect changes in atrial conduction,
which may be due to a variety of etiologies. Thus, the term
atrial "abnormality" may be more appropriate than
"enlargement" to describe such ECG findings.
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